Last update 01 Nov 2024
Changshu Lei Yun Shang Pharmaceutical Co. Ltd.

Changshu Lei Yun Shang Pharmaceutical Co. Ltd.

Private Company|
1998|
Jiangsu Sheng, China
|
100-250
|
www.cslys.com.cn

Overview

Tags

Hemic and Lymphatic Diseases
Herbal medicine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Hemic and Lymphatic Diseases1
Top 5 Drug TypeCount
Herbal medicine1

Related

1
Drugs associated with Changshu Lei Yun Shang Pharmaceutical Co. Ltd.
Shuanghuang Shengbai Oral Liquid
Target-
Mechanism-
Active Org.
Longhua Hospital Shanghai University of TCM [+1]
Originator Org.-
Active Indication
Neutropenia
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Changshu Lei Yun Shang Pharmaceutical Co. Ltd.
CTR20190526 / RecruitingPhase 2
双黄升白口服液治疗原发性非小细胞肺腺癌患者因化疗所致Ⅰ、Ⅱ度中性粒细胞减少（精气两亏证）的有效性和安全性的随机、双盲、安慰剂平行对照、多中心Ⅱ期临床研究
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase II clinical study on the efficacy and safety of Shuanghuang Shengbai oral liquid in the treatment of grade I and II neutropenia (deficiency of both essence and qi) caused by chemotherapy in patients with primary non-small cell lung adenocarcinoma
100 Clinical Results associated with Changshu Lei Yun Shang Pharmaceutical Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Changshu Lei Yun Shang Pharmaceutical Co. Ltd.
Login to view more data
100 Deals associated with Changshu Lei Yun Shang Pharmaceutical Co. Ltd.
Login to view more data
100 Translational Medicine associated with Changshu Lei Yun Shang Pharmaceutical Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 02 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Shuanghuang Shengbai Oral Liquid
Neutropenia
More
Phase 2
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free